JEFFREY W SHERMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY W SHERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY W SHERMAN. JEFFREY W SHERMAN is Ex VP & Chief Medical Officer in NEOPHARM INC ($NEOL) and EX. VP in NEOPHARM INC ($NEOL) and Executive V.P. in NEOPHARM INC ($NEOL) and Director in XERIS PHARMACEUTICALS INC ($XERS) and EVP and Chief Medical Officer in Horizon Pharma plc ($HZNP) and Director in Strongbridge Biopharma plc ($SBBP).
Latest Insider Trading Transactions of JEFFREY W SHERMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HZNP, NEOL, SBBP, XERS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 12,094 | 0 | 24,190 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 17,260 | 0 | 0 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 12,261 | 0 | 12,261 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 27,942 | 0 | 27,942 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 73.28 | 45,256 | 3,316,360 | 84,687 | 129.9 K to 84.7 K (-34.83 %) |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Grant | A | 0.00 | 60,313 | 0 | 129,943 | 69.6 K to 129.9 K (+86.62 %) |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 41,615 | 0 | 69,630 | 28 K to 69.6 K (+148.55 %) |
| Dec 09 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 71.32 | 31,133 | 2,220,406 | 174,955 | 206.1 K to 175 K (-15.11 %) |
| Dec 09 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 70.60 | 9,631 | 679,949 | 206,088 | 215.7 K to 206.1 K (-4.46 %) |
| Dec 09 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 72.24 | 10,489 | 757,725 | 215,719 | 226.2 K to 215.7 K (-4.64 %) |
| Dec 09 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 71.52 | 16,200 | 1,158,624 | 226,208 | 242.4 K to 226.2 K (-6.68 %) |
| Dec 09 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 70.31 | 36,389 | 2,558,511 | 242,408 | 278.8 K to 242.4 K (-13.05 %) |
| Oct 21 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 7.61 | 13,000 | 98,930 | 57,000 | |
| Oct 21 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 7.61 | 13,000 | 98,930 | 28,015 | 15 K to 28 K (+86.58 %) |
| Jul 07 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 57.50 | 9,100 | 523,250 | 278,797 | 287.9 K to 278.8 K (-3.16 %) |
| Jun 04 2020 | XERS | XERIS PHARMACEUTIC ... | SHERMAN JEFFREY W | Director | Option Exercise | A | 4.68 | 11,228 | 52,547 | 11,228 | |
| May 18 2020 | SBBP | Strongbridge Bioph ... | SHERMAN JEFFREY W | Director | Payment of Exercise | F | 2.86 | 19,035 | 54,440 | 60,965 | 80 K to 61 K (-23.79 %) |
| May 18 2020 | SBBP | Strongbridge Bioph ... | SHERMAN JEFFREY W | Director | Payment of Exercise | F | 2.86 | 19,035 | 54,440 | 60,965 | 80 K to 61 K (-23.79 %) |
| May 15 2020 | SBBP | Strongbridge Bioph ... | SHERMAN JEFFREY W | Director | Grant | A | 0.00 | 40,000 | 0 | 80,000 | 40 K to 80 K (+100.00 %) |
| May 12 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 4.96 | 33,479 | 166,056 | 0 | |
| May 12 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 45.00 | 33,479 | 1,506,555 | 13,966 | 47.4 K to 14 K (-70.56 %) |
| May 12 2020 | HZNP | Horizon Therapeuti ... | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 4.96 | 33,479 | 166,056 | 47,445 | 14 K to 47.4 K (+239.72 %) |
| May 16 2019 | SBBP | Strongbridge Bioph ... | SHERMAN JEFFREY W | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Mar 01 2019 | XERS | XERIS PHARMACEUTIC ... | SHERMAN JEFFREY W | Director | Option Exercise | A | 10.00 | 20,000 | 200,000 | 20,000 | |
| Mar 01 2019 | XERS | XERIS PHARMACEUTIC ... | SHERMAN JEFFREY W | Director | Option Exercise | A | 10.00 | 20,000 | 200,000 | 20,000 | |
| May 17 2018 | SBBP | Strongbridge Bioph ... | SHERMAN JEFFREY W | Director | Option Exercise | A | 7.75 | 40,000 | 310,000 | 40,000 | |
| Mar 27 2018 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 19,250 | 0 | 19,250 | |
| Mar 27 2018 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 13.86 | 8,528 | 118,198 | 212,341 | 220.9 K to 212.3 K (-3.86 %) |
| Mar 27 2018 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 19,250 | 0 | 220,869 | 201.6 K to 220.9 K (+9.55 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 19,250 | 0 | 38,500 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 14.56 | 8,798 | 128,099 | 192,350 | 201.1 K to 192.4 K (-4.37 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 19,250 | 0 | 201,148 | 181.9 K to 201.1 K (+10.58 %) |
| Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 15,500 | 0 | 15,500 | |
| Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 11,250 | 0 | 0 | |
| Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 16.18 | 12,602 | 203,900 | 181,898 | 194.5 K to 181.9 K (-6.48 %) |
| Jan 04 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 26,750 | 0 | 194,500 | 167.8 K to 194.5 K (+15.95 %) |
| Dec 19 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 2.40 | 8,500 | 20,400 | 5,313 | |
| Dec 19 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 2.40 | 8,500 | 20,400 | 167,750 | 159.3 K to 167.8 K (+5.34 %) |
| Aug 02 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 20.00 | 2,900 | 58,000 | 159,250 | 162.2 K to 159.3 K (-1.79 %) |
| Mar 24 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 19,250 | 0 | 57,750 | |
| Mar 24 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 16.32 | 8,798 | 143,583 | 160,100 | 168.9 K to 160.1 K (-5.21 %) |
| Mar 24 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 19,250 | 0 | 168,898 | 149.6 K to 168.9 K (+12.86 %) |
| Feb 29 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 20.00 | 4,100 | 82,000 | 149,648 | 153.7 K to 149.6 K (-2.67 %) |
| Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 15,500 | 0 | 31,000 | |
| Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 11,250 | 0 | 11,250 | |
| Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 21.67 | 8,576 | 185,842 | 153,748 | 162.3 K to 153.7 K (-5.28 %) |
| Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 26,750 | 0 | 162,324 | 135.6 K to 162.3 K (+19.73 %) |
| Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 4.96 | 17,692 | 87,752 | 33,479 | |
| Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 2.40 | 12,750 | 30,600 | 13,813 | |
| Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 4.96 | 17,692 | 87,752 | 135,574 | 117.9 K to 135.6 K (+15.01 %) |
| Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 2.40 | 12,750 | 30,600 | 117,882 | 105.1 K to 117.9 K (+12.13 %) |
| Dec 10 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | S | 20.00 | 4,456 | 89,120 | 105,132 | 100.7 K to 105.1 K (+4.43 %) |
| Dec 09 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 8,208 | 0 | 0 | |
| Dec 09 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 21.40 | 3,752 | 80,293 | 109,588 | 113.3 K to 109.6 K (-3.31 %) |
| Dec 09 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 8,208 | 0 | 113,340 | 105.1 K to 113.3 K (+7.81 %) |
| Sep 21 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 31.78 | 7,750 | 246,295 | 105,132 | 112.9 K to 105.1 K (-6.87 %) |
| Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 4.96 | 2,450 | 12,152 | 51,171 | |
| Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 2.40 | 24,437 | 58,649 | 26,563 | |
| Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 35.55 | 2,450 | 87,098 | 112,882 | 115.3 K to 112.9 K (-2.12 %) |
| Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 4.96 | 2,450 | 12,152 | 115,332 | 112.9 K to 115.3 K (+2.17 %) |
| Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 35.55 | 24,437 | 868,735 | 112,882 | 137.3 K to 112.9 K (-17.80 %) |
| Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 2.40 | 24,437 | 58,649 | 137,319 | 112.9 K to 137.3 K (+21.65 %) |
| May 08 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 558,000 | 0 | 558,000 | |
| Mar 25 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 186,000 | 0 | 186,000 | |
| Mar 25 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 77,000 | 0 | 77,000 | |
| Mar 25 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | A | 22.14 | 173,000 | 3,830,220 | 173,000 | |
| May 02 2005 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Executive V.P. | Option Exercise | A | 7.95 | 29,100 | 231,345 | 29,100 | |
| May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Gift | G | 0.00 | 100 | 0 | 214,186 | 214.3 K to 214.2 K (-0.05 %) |
| May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Buy | P | 14.06 | 100 | 1,406 | 214,186 | 214.1 K to 214.2 K (+0.05 %) |
| May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Gift | G | 0.00 | 100 | 0 | 214,186 | 214.3 K to 214.2 K (-0.05 %) |
| May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Buy | P | 14.06 | 100 | 1,406 | 214,186 | 214.1 K to 214.2 K (+0.05 %) |
| Feb 18 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Ex VP & Chief Medic ... | Option Exercise | A | 19.91 | 30,000 | 597,300 | 30,000 |
Page: 1